MM-039: Natural History of Skeletal-Related Events Among 620 Patients with Multiple Myeloma Who Received First- and Second-Line Therapy with Novel Agents: A Single-Center Analysis

Evangelos Terpos; Nikolaos Kanellias; Eftathios Kastritis; Maria Gavriatopoulou; Vassilis Koutoulidis; Ioannis Ntanasis‐Stathopoulos; Αριστέα-Μαρία Παπανώτα; Despina Fotiou; Magdalini Migkou; Evangelos Eleutherakis‐Papaiakovou; Panagiotis Malandrakis; Tina Bagratuni; Μαρία Ρούσσου; Lia A. Moulopoulos; Meletios A Dimopoulos

doi:10.1016/s2152-2650(20)30916-2

Article2019

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

Evangelos Terpos, Nikolaos Kanellias, Eftathios Kastritis, Maria Gavriatopoulou, Vassilis Koutoulidis, Ioannis Ntanasis‐Stathopoulos, Αριστέα-Μαρία Παπανώτα, Despina Fotiou, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Panagiotis Malandrakis, Tina Bagratuni, Μαρία Ρούσσου, Lia A. Moulopoulos, Meletios A Dimopoulos

Article2019

Incidence of Skeletal-Related Events at Diagnosis and at the Time of First Relapse in 463 Patients with Multiple Myeloma Who Received First Line Treatment in a Single Center

Evangelos Terpos, Nikolaos Kanellias, Lia A. Moulopoulos, Dimitrios Christoulas, Maria Gavriatopoulou, Magdalini Migkou, Tina Bagratuni, Vassilis Koutoulidis, Efstathios Kastritis, Meletios A Dimopoulos

Article2022

MM-468 Longitudinal Assessment of Minimal Residual Disease Dynamics in Patients With Multiple Myeloma who Achieve Complete Response after First Line Therapy

loannis Kostopoulos, Loannis Ntanasis-Stathopoulos, Nikolaos Aggelis, Panos Malandrakis, Evangelos Eleftherakis-Papaiakovou, Pantelis Rousakis, Chrysanthi Panteli, Nikolaos Kanelias, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Ourania Tsitsilonis, Meletios A Dimopoulos, Evangelos Terpos

Article2013

Skeletal-Related Events In Patients With Multiple Myeloma In The Era Of Novel Agents: Low Incidence Of Pathological Fractures After Treatment

Evangelos Terpos, Nikolaos Kanellias, Lia A. Moulopoulos, Dimitrios Christoulas, Ανδρέας Κουρέας, Tina Bagratuni, Vassilis Koutoulidis, Efstathios Kastritis, Meletios A Dimopoulos

Article2022

Poster: MM-468 Longitudinal Assessment of Minimal Residual Disease Dynamics in Patients With Multiple Myeloma who Achieve Complete Response after First Line Therapy

Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Nikolaos Aggelis, Panos Malandrakis, Evangelos Eleftherakis-Papaiakovou, Pantelis Rousakis, Chrysanthi Panteli, Nikolaos Kanelias, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Ourania Tsitsilonis, Meletios A Dimopoulos, Evangelos Terpos

MM-039: Natural History of Skeletal-Related Events Among 620 Patients with Multiple Myeloma Who Received First- and Second-Line Therapy with Novel Agents: A Single-Center Analysis

Discussion(0)

Related publications

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

Incidence of Skeletal-Related Events at Diagnosis and at the Time of First Relapse in 463 Patients with Multiple Myeloma Who Received First Line Treatment in a Single Center

MM-468 Longitudinal Assessment of Minimal Residual Disease Dynamics in Patients With Multiple Myeloma who Achieve Complete Response after First Line Therapy

Skeletal-Related Events In Patients With Multiple Myeloma In The Era Of Novel Agents: Low Incidence Of Pathological Fractures After Treatment

Poster: MM-468 Longitudinal Assessment of Minimal Residual Disease Dynamics in Patients With Multiple Myeloma who Achieve Complete Response after First Line Therapy